TauroLock™-HEP500 can be used with devices for venous vascular access. We recommend using it with catheters for haemodialysis. This lock solution prevents the formation of bacterial biofilm: Patients remain protected against catheter-related infections and maintain a high patency rate. 

TauroLock™-HEP500 consists of three active ingredients:

• taurolidine
• heparin (500 units per ml)
• citrate (4 %)

Taurolidine has a broad antimicrobial activity (incl. MRSA and VRE) against gram-positive and gram-negative bacteria and fungi (e.g. Candida). Heparin and citrate both prevent occlusions within the catheter. 

In-between treatment sessions, TauroLock™-HEP500 is instilled into the vascular access system. Please note that medical staff have to check the filling volume of the respective catheter or port system.